title: Sunitinib-induced sudden hearing loss.
authors.affiliation: Department of Medical Oncology, Hospices Civils de Lyon, Hôpital Edouard Herriot, 69437, Lyon cedex 03, France. Kathleen.dekeister@gmail.com.
authors.forename: Kathleen
authors.initials: K
authors.lastname: Dekeister
authors.affiliation: Department of Medical Oncology, Hospices Civils de Lyon, Hôpital Edouard Herriot, 69437, Lyon cedex 03, France.
authors.forename: Emmanuelle
authors.initials: E
authors.lastname: Graillot
authors.affiliation: Department of ENT (ear, nose and throat), Hospices Civils de Lyon, Hôpital Edouard Herriot, 69437, Lyon cedex 03, France.
authors.forename: Mickaël
authors.initials: M
authors.lastname: Durbec
authors.affiliation: Department of Medical Biology and Pathology, Institut Gustave Roussy, 94805, Villejuif cedex, France.
authors.forename: Jean-Yves
authors.initials: JY
authors.lastname: Scoazec
authors.affiliation: Department of Medical Oncology, Hospices Civils de Lyon, Hôpital Edouard Herriot, 69437, Lyon cedex 03, France.|Université de Lyon, Université Claude Bernard Lyon 1, 69622, Villeurbanne cedex, France.
authors.forename: Thomas
authors.initials: T
authors.lastname: Walter
mesh_terms: D017322:Clinical Trials, Phase II as Topic; D005260:Female; D003639:Hearing Loss, Sudden / Q000139:chemically induced*; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D018358:Neuroendocrine Tumors / Q000150:complications / Q000188:drug therapy / Q000473:pathology; D011758:Pyrroles / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D000077210:Sunitinib; D014012:Tinnitus / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced
chemical_list: D007211:Indoles; D011758:Pyrroles; D000077210:Sunitinib
keywords: Hearing loss; Side effect; Sunitinib